A Woburn biotechnology company laid off more than 200 Massachusetts employees last week, and state filings warn more cuts may ...
This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...
Replimune has again failed to win regulatory approval for a new drug treating skin cancer, and the result is more than 220 ...
Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...
4don MSN
Mass. biotech company facing between 161 and 224 layoffs after FDA rejects drug for 2nd time
A Woburn biotechnology company is now facing a significantly larger wave of layoffs than initially disclosed — with state filings suggesting between 161 and 224 Massachusetts employees are on the ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation ...
If biotech funding continues to increase this year, Danaher could benefit.
(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...
EVERETT — Sana Biotechnology has canceled plans to build a major biotech manufacturing factory in Bothell that was supposed to employ hundreds of workers within a few years. The publicly traded ...
Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results